Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Clinical trial NCT06602531 · COMPLETED

Trial details

NCT number: NCT06602531
Sponsor: Arcturus Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2024-12-10
Primary completion: 2025-06-13
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.